Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00535-016-1204-2.

Title:
Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON | Journal of Gastroenterology
Description:
GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Insurance
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

patients, sorafenib, childpugh, article, hepatocellular, carcinoma, japan, treatment, pubmed, aes, google, scholar, study, bclc, liver, stage, japanese, drugrelated, safety, incidence, analysis, gideon, cancer, therapy, hcc, ttp, tace, higher, score, median, cas, table, data, kudo, surveillance, received, efficacy, regions, shown, months, rate, pharma, pharmaceutical, number, time, similar, practice, global, start, sessions,

Topics {✒️}

hand-foot skin reaction article download pdf raf/mek/erk pathway post-marketing surveillance manager gideon original article—liver hepatocellular carcinoma–current status intermediate-stage hepatocellular carcinoma treatment-emergent death occurring worse child-pugh score transarterial chemoembolization failure/refractoriness drug-related aes reported child-pugh score worsened open-label study real-world practice data advanced hepatocellular carcinoma oral multikinase inhibitor baseline child-pugh status privacy choices/manage cookies satoshi yamashita related subjects full access drug-related aes author information authors daily medical practice complex medical situation cancer-related death real-world practice masatoshi kudo hepatic-related events transcatheter arterial chemoembolization drug-related saes article kudo abnormal laboratory tests nat rev cancer metastatic colorectal cancer molecular mechanisms involved conditions privacy policy phase iii randomised unresectable hepatocellular carcinoma outpatients diagnosed histologically decreased platelet count advisory committee immediately aliment pharmacol ther ethics declarations conflict kyowa hakko kirin bristol-myers squibb response evaluation criteria decrease patient quality advanced bclc stage limit daily activities

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
         description:GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
         datePublished:2016-04-22T00:00:00Z
         dateModified:2016-04-22T00:00:00Z
         pageStart:1150
         pageEnd:1160
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00535-016-1204-2
         keywords:
            Hepatocellular carcinoma
            Sorafenib
            Japanese
            GIDEON
            Gastroenterology
            Hepatology
            Abdominal Surgery
            Colorectal Surgery
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig2_HTML.gif
         isPartOf:
            name:Journal of Gastroenterology
            issn:
               1435-5922
               0944-1174
            volumeNumber:51
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Japan
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Masatoshi Kudo
               affiliation:
                     name:Kinki University School of Medicine
                     address:
                        name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Masafumi Ikeda
               affiliation:
                     name:National Cancer Center Hospital East
                     address:
                        name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tadatoshi Takayama
               affiliation:
                     name:Nihon University School of Medicine
                     address:
                        name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kazushi Numata
               affiliation:
                     name:Yokohama City University Medical Center
                     address:
                        name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Namiki Izumi
               affiliation:
                     name:Musashino Red Cross Hospital
                     address:
                        name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junji Furuse
               affiliation:
                     name:Kyorin University
                     address:
                        name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takuji Okusaka
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masumi Kadoya
               affiliation:
                     name:Shinshu University School of Medicine
                     address:
                        name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Satoshi Yamashita
               affiliation:
                     name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
                     address:
                        name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuichiro Ito
               affiliation:
                     name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
                     address:
                        name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Norihiro Kokudo
               affiliation:
                     name:Graduate School of Medicine, University of Tokyo
                     address:
                        name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
      description:GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
      datePublished:2016-04-22T00:00:00Z
      dateModified:2016-04-22T00:00:00Z
      pageStart:1150
      pageEnd:1160
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00535-016-1204-2
      keywords:
         Hepatocellular carcinoma
         Sorafenib
         Japanese
         GIDEON
         Gastroenterology
         Hepatology
         Abdominal Surgery
         Colorectal Surgery
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig2_HTML.gif
      isPartOf:
         name:Journal of Gastroenterology
         issn:
            1435-5922
            0944-1174
         volumeNumber:51
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Japan
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Masatoshi Kudo
            affiliation:
                  name:Kinki University School of Medicine
                  address:
                     name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Masafumi Ikeda
            affiliation:
                  name:National Cancer Center Hospital East
                  address:
                     name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tadatoshi Takayama
            affiliation:
                  name:Nihon University School of Medicine
                  address:
                     name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kazushi Numata
            affiliation:
                  name:Yokohama City University Medical Center
                  address:
                     name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Namiki Izumi
            affiliation:
                  name:Musashino Red Cross Hospital
                  address:
                     name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junji Furuse
            affiliation:
                  name:Kyorin University
                  address:
                     name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takuji Okusaka
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masumi Kadoya
            affiliation:
                  name:Shinshu University School of Medicine
                  address:
                     name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Satoshi Yamashita
            affiliation:
                  name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
                  address:
                     name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuichiro Ito
            affiliation:
                  name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
                  address:
                     name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Norihiro Kokudo
            affiliation:
                  name:Graduate School of Medicine, University of Tokyo
                  address:
                     name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Gastroenterology
      issn:
         1435-5922
         0944-1174
      volumeNumber:51
Organization:
      name:Springer Japan
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Kinki University School of Medicine
      address:
         name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
         type:PostalAddress
      name:National Cancer Center Hospital East
      address:
         name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
         type:PostalAddress
      name:Nihon University School of Medicine
      address:
         name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Yokohama City University Medical Center
      address:
         name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
         type:PostalAddress
      name:Musashino Red Cross Hospital
      address:
         name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
         type:PostalAddress
      name:Kyorin University
      address:
         name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:Shinshu University School of Medicine
      address:
         name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
         type:PostalAddress
      name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
      address:
         name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
         type:PostalAddress
      name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
      address:
         name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
         type:PostalAddress
      name:Graduate School of Medicine, University of Tokyo
      address:
         name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Masatoshi Kudo
      affiliation:
            name:Kinki University School of Medicine
            address:
               name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Masafumi Ikeda
      affiliation:
            name:National Cancer Center Hospital East
            address:
               name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:Tadatoshi Takayama
      affiliation:
            name:Nihon University School of Medicine
            address:
               name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Kazushi Numata
      affiliation:
            name:Yokohama City University Medical Center
            address:
               name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
               type:PostalAddress
            type:Organization
      name:Namiki Izumi
      affiliation:
            name:Musashino Red Cross Hospital
            address:
               name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Junji Furuse
      affiliation:
            name:Kyorin University
            address:
               name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Takuji Okusaka
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Masumi Kadoya
      affiliation:
            name:Shinshu University School of Medicine
            address:
               name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
               type:PostalAddress
            type:Organization
      name:Satoshi Yamashita
      affiliation:
            name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
            address:
               name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
               type:PostalAddress
            type:Organization
      name:Yuichiro Ito
      affiliation:
            name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
            address:
               name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
               type:PostalAddress
            type:Organization
      name:Norihiro Kokudo
      affiliation:
            name:Graduate School of Medicine, University of Tokyo
            address:
               name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
      name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
      name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
      name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
      name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
      name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
      name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
      name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
      name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
      name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

External Links {🔗}(138)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.34s.